389
Views
3
CrossRef citations to date
0
Altmetric
Asthma Outcomes

Clinical outcomes among hospitalized US adults with asthma or chronic obstructive pulmonary disease, with or without COVID-19

, MSPHORCID Icon, , MD, MS, , PhD, MSORCID Icon, , PhD, MPHORCID Icon, , MD, DScORCID Icon & , PhD, MPHORCID Icon
Pages 2509-2519 | Received 01 Jul 2021, Accepted 11 Dec 2021, Published online: 29 Dec 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Chia Siang Kow, Dinesh Sangarran Ramachandram & Syed Shahzad Hasan. (2023) Early Oxygen Therapy may be Beneficial to Patients with COVID-19 and Underlying Pulmonary Diseases. Journal of Asthma 60:2, pages 422-423.
Read now

Articles from other publishers (2)

Emek Kocatürk, Elissa M. Abrams, Marcus Maurer, Jad Mitri, John Oppenheimer, Christian Vestergaard & Joe Zein. (2023) COVID-19 and Its Impact on Common Diseases in the Allergy Clinics. The Journal of Allergy and Clinical Immunology: In Practice 11:11, pages 3289-3303.
Crossref
Evangelia Koukaki, Zoi Sotiropoulou, Angelos Vontetsianos, Stavroula Zaneli, Agamemnon Bakakos, Sevasti Ampelioti, Anna Kyriakoudi, Andriana Ι. Papaioannou, Antonia Koutsoukou & Nikoletta Rovina. (2023) Critically ill COVID-19 patients with obstructive pulmonary diseases: Characteristics, risk factors and outcome. Pneumon 36:2, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.